- Home
- SEMR vs CLDX Comparison
SEMR vs CLDX Comparison
Compare SEMR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEMR
- CLDX
- Stock Information
- Founded
- SEMR 2008
- CLDX N/A
- Country
- SEMR United States
- CLDX United States
- Employees
- SEMR N/A
- CLDX N/A
- Industry
- SEMR EDP Services
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SEMR Technology
- CLDX Health Care
- Exchange
- SEMR Nasdaq
- CLDX Nasdaq
- Market Cap
- SEMR 1.3B
- CLDX 1.3B
- IPO Year
- SEMR 2021
- CLDX 2008
- Fundamental
- Price
- SEMR $9.41
- CLDX $22.81
- Analyst Decision
- SEMR Buy
- CLDX Buy
- Analyst Count
- SEMR 8
- CLDX 9
- Target Price
- SEMR $17.00
- CLDX $50.00
- AVG Volume (30 Days)
- SEMR 798.5K
- CLDX 865.2K
- Earning Date
- SEMR 08-04-2025
- CLDX 08-11-2025
- Dividend Yield
- SEMR N/A
- CLDX N/A
- EPS Growth
- SEMR N/A
- CLDX N/A
- EPS
- SEMR 0.05
- CLDX N/A
- Revenue
- SEMR $396,021,000.00
- CLDX $7,559,000.00
- Revenue This Year
- SEMR $21.85
- CLDX N/A
- Revenue Next Year
- SEMR $18.50
- CLDX N/A
- P/E Ratio
- SEMR $198.37
- CLDX N/A
- Revenue Growth
- SEMR 22.75
- CLDX 24.49
- 52 Week Low
- SEMR $7.90
- CLDX $14.40
- 52 Week High
- SEMR $18.74
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- SEMR 51.03
- CLDX 54.64
- Support Level
- SEMR $8.60
- CLDX $21.57
- Resistance Level
- SEMR $10.00
- CLDX $24.06
- Average True Range (ATR)
- SEMR 0.32
- CLDX 1.11
- MACD
- SEMR 0.09
- CLDX -0.11
- Stochastic Oscillator
- SEMR 57.14
- CLDX 49.80
About SEMR SEMrush Holdings Inc.
SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.